Biocon Limited

BIOCON · Healthcare

About Biocon Limited (BIOCON)

Biocon Limited is a Biotechnology company operating in the Healthcare sector.

BIOCON trades on the Indian stock exchanges (NSE/BSE) and is classified as a large-cap stock .

Sector
Healthcare
Industry
Biotechnology

Key Statistics

Current Price
₹351.80
Market Cap
₹576.16B
52-Week High
₹447.15
52-Week Low
₹318.40
Sector
Healthcare
Industry
Biotechnology

₹1,000 Invested in Biocon Limited (BIOCON)

1 Year
₹980
+-2%
3 Years
₹1,356
+36%
5 Years
₹993
+-1%
10 Years
₹2,510
+151%
Since IPO
₹10,291
+929%

How much would ₹1,000 invested in BIOCON be worth today?

What would ₹1,000 invested in BIOCON 1 year ago be worth today?

A ₹1,000 investment in Biocon Limited (BIOCON) in 2025 would be worth ₹980 as of November 2026, representing a -2.0% total return.

What would ₹1,000 invested in BIOCON 3 years ago be worth today?

A ₹1,000 investment in Biocon Limited (BIOCON) in 2023 would be worth ₹1,356 as of November 2026, representing a +35.6% total return.

What would ₹1,000 invested in BIOCON 5 years ago be worth today?

A ₹1,000 investment in Biocon Limited (BIOCON) in 2021 would be worth ₹993 as of November 2026, representing a -0.7% total return.

What would ₹1,000 invested in BIOCON 10 years ago be worth today?

A ₹1,000 investment in Biocon Limited (BIOCON) in 2016 would be worth ₹2,510 as of November 2026, representing a +151.0% total return.

What would ₹1,000 invested in BIOCON at IPO be worth today?

A ₹1,000 investment in Biocon Limited (BIOCON) at IPO would be worth ₹10,291 as of November 2026, representing a +929.1% total return.

Monthly Returns Heatmap

Avg Monthly Return
+1.28%
Positive Months
147
54% of 270
Negative Months
123
46% of 270
Data Period
22+ years
270 months
Best Performers
Best month ever: Mar 2009 (+40.7%)
Best month on avg: April (+5.8%)
Worst Performers
Worst month ever: Oct 2008 (-46.8%)
Worst month on avg: January (-4.5%)

Over the past 22+ years (270 months), Biocon Limited (BIOCON) has averaged a monthly return of +1.28% with a median return of +0.61%. The stock had 147 positive months (54%) and 123 negative months (46%). The best month in BIOCON's history was March 2009 with a +40.7% return, while the worst was October 2008 at -46.8%. Historically, April tends to be the strongest month (averaging +5.8%), and January the weakest (-4.5%).

BIOCON's longest winning streak was 7 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2009 with a cumulative return of +101.6%, and the worst was 2008 at -55.8%.

Annual Returns

Over 22 years of trading history, Biocon Limited (BIOCON) has delivered an average annual return of +19.70% with a median return of +7.44%. The compound annual growth rate (CAGR) is +10.91%. The stock posted gains in 12 years (55%) and losses in 10 years (45%).

BIOCON's best year was 2009 with a +140.10% gain, while the worst was 2008 at -59.09%. The longest streak of consecutive positive years was 4, and the longest losing streak was 3 years. BIOCON achieved double-digit gains (10%+) in 10 years. It suffered double-digit losses in 6 years.

Avg Return
+19.70%
Best Year
2009 (+140.10%)
Worst Year
2008 (-59.09%)
Positive Years
12/22
Year Return Start End
2026 -10.58% ₹393.43 ₹351.80
2025 +7.96% ₹364.43 ₹393.43
2024 +46.55% ₹248.67 ₹364.43
2023 -4.10% ₹259.32 ₹248.67
2022 -28.08% ₹360.54 ₹259.32
2021 -21.65% ₹460.16 ₹360.54
2020 +58.46% ₹290.39 ₹460.16
2019 -6.44% ₹310.39 ₹290.39
2018 +17.28% ₹264.67 ₹310.39
2017 +70.11% ₹155.59 ₹264.67
2016 +85.29% ₹83.97 ₹155.59
2015 +23.02% ₹68.26 ₹83.97
2014 -7.11% ₹73.48 ₹68.26
2013 +65.59% ₹44.38 ₹73.48
2012 +6.92% ₹41.50 ₹44.38
2011 -34.12% ₹63.00 ₹41.50
2010 +54.15% ₹40.87 ₹63.00
2009 +140.10% ₹17.02 ₹40.87
2008 -59.09% ₹41.61 ₹17.02
2007 +55.49% ₹26.76 ₹41.61
2006 -24.00% ₹35.21 ₹26.76
2005 -2.26% ₹36.02 ₹35.21

Frequently Asked Questions: BIOCON

What sector is BIOCON in? ▼

BIOCON operates in the Healthcare sector, specifically in the Biotechnology industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.

How has BIOCON performed historically? ▼

Over 22 years of trading history, BIOCON has posted gains in 12 years (55% of the time). The best year was 2009 with a +140.1% return. Past performance does not guarantee future results.

How can I invest in BIOCON? ▼

You can invest in BIOCON through any brokerage account that offers access to Indian exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold BIOCON.

Last updated: 11/1/2026